Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-34236

Stojic, L; Cejka, P; Jiricny, J (2005). High doses of SN1 type methylating agents activate DNA damage signaling cascades that are largely independent of mismatch repair. Cell Cycle, 4(3):473-477.

[img]PDF - Registered users only
572Kb

Abstract

Methylating agents of the SN1 type represent an important class of cancer chemotherapeutics. Efficient killing by clinically-relevant doses of these agents requires cell division and low levels or absence of the repair enzyme methylguanine methyl transferase (MGMT). The process requires also an active mismatch repair (MMR) system, as treatment of cells with the prototypic methylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) could be shown to trigger a delayed cell cycle arrest, which was absolutely MMR-dependent. We now show that DNA damage signaling activated by high doses of MNNG is very rapid and largely MMR-independent. However, the MMR system still contributes towards cell killing, as MMR deficiency favors the long-term survival of the cells, albeit to a substantially smaller extent than when low MNNG concentrations are deployed.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Molecular Cancer Research
07 Faculty of Science > Institute of Molecular Cancer Research
DDC:570 Life sciences; biology
Language:English
Date:2005
Deposited On:09 Jul 2010 12:38
Last Modified:02 Dec 2013 21:33
Publisher:Landes Bioscience
ISSN:1551-4005
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:10.4161/cc.4.3.1528
Official URL:http://www.landesbioscience.com/journals/cc/article/1528/
PubMed ID:15684614
Citations:Web of Science®. Times Cited: 30
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page